Novartis (NVS) Q3 2021 Earnings Call Transcript

NVS earnings call for the period ending September 30, 2021.

Related Keywords

Germany ,Japan ,United States ,Egypt ,China ,Italy ,Saudi Arabia ,Austria ,Russia ,France ,Austrian ,Graham Parry ,Andrew Baum ,Susanne Schaffert ,Laura Sutcliffe ,Harry Kirsch ,Samir Shah ,Lilly Verzenio ,Andrew Baum Citi ,Seamus Fernandez Guggenheim ,Simon Baker Redburn ,Keyur Parekh ,Sarita Kapila Morgan Stanley ,Sarita Kapila ,John Tsai ,Richard Parkes ,Tim Anderson ,Steffen Lang ,Florent Cespedes ,Richard Wagner ,Richard Parkes Exane ,Florent Cespedes Societe Generale ,Simon Baker ,Emmanuel Papadakis ,Wimal Kapadia ,Naresh Chouhan ,America Merrill Lynch ,Peter Welford Jefferies ,Stefan Schneider ,Keyur Parekh Goldman Sachs ,Seamus Fernandez ,Peter Welford ,Jo Walton ,Richard Vosser ,Promacta Revolade ,Richard Saynor ,Morgan Stanley ,Richard Wagner Wolfe Research Analyst ,Goldman Sachs ,Emmanuel Papadakis Deutsche Bank Analyst ,Credit Suisse ,Graham Parry Bank ,Naresh Chouhan Intron Health Analyst ,Deutsche Bank ,Novartis ,Pfizer ,Intron Health ,Exchange Commission ,Wolfe Research ,Innovative Medicines ,Executive Officer ,Fast Track ,Innovative Medicine ,Capital Markets Day ,Meet Novartis Management ,Chief Medical ,Chief Executive Officer ,Guggenheim Partners ,Societe Generale ,